Magnetic Resonance Imaging for Monitoring of Magnetic Polyelectrolyte Capsule In Vivo Delivery

Qiangying Yi, Danyang Li, Bingbing Lin, Anton M. Pavlov, Dong Luo, Qiyong Gong, Bin Song, Hua Ai, Gleb B. Sukhorukov

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Layer-by-layer (LbL) assembled polyelectrolyte capsules have been widely studied as promising delivery systems due to their well-controlled architectures. Although their potential applications in vitro have been widely investigated, at present, it is still a challenging task to track their real-time delivery in vivo, where and how they would be located following their administration. In this work, the noninvasive magnetic resonance imaging (MRI) technique was applied to monitor the delivery of polyelectrolyte capsules in vivo, incorporating magnetite nanoparticles as imaging components. First, MRI scan was performed over 6 h after sample administration at the magnetic field of 3.0 T; magnetic capsules, both poly(allylamine hydrochloride)/poly(styrenesulfonate sodium salt)-based and poly-l-arginine hydrochloride/dextran sulfate (Parg/DS)-based, were detected mostly in the liver region, where the transverse relaxation time (T2) was shortened and hypointense images were visualized, demonstrating a contrast-enhanced MRI effect between liver and adjacent tissue. A continuous MRI scan found that the contrast-enhanced MRI effect can last up to 30 h; in the mean time, the Parg/DS-based capsules with smaller diameter were found to have a pronounced clearance effect, which resulted in a weakened MRI effect in the liver. No obvious toxicity was found in animal studies, and all mice survived after MRI scans. Histology study provided evidences to support the MRI results, and also revealed the destination of these magnetic capsules over 30 h after administration.

Original languageEnglish
Pages (from-to)59-70
Number of pages12
JournalBioNanoScience
Volume4
Issue number1
DOIs
Publication statusPublished - 1 Mar 2014
Externally publishedYes

Fingerprint

Polyelectrolytes
Magnetic resonance
Capsules
Imaging techniques
Monitoring
Liver
Dextran Sulfate
Arginine
Dextran
Magnetite Nanoparticles
Magnetite nanoparticles
Magnetic Resonance Imaging
Histology
Relaxation time
Toxicity
Animals
Salts
Sodium
Tissue
Magnetic fields

Keywords

  • Capsule
  • Liver
  • Magnetite
  • MRI
  • Spleen

ASJC Scopus subject areas

  • Bioengineering
  • Biomedical Engineering

Cite this

Magnetic Resonance Imaging for Monitoring of Magnetic Polyelectrolyte Capsule In Vivo Delivery. / Yi, Qiangying; Li, Danyang; Lin, Bingbing; Pavlov, Anton M.; Luo, Dong; Gong, Qiyong; Song, Bin; Ai, Hua; Sukhorukov, Gleb B.

In: BioNanoScience, Vol. 4, No. 1, 01.03.2014, p. 59-70.

Research output: Contribution to journalArticle

Yi, Qiangying ; Li, Danyang ; Lin, Bingbing ; Pavlov, Anton M. ; Luo, Dong ; Gong, Qiyong ; Song, Bin ; Ai, Hua ; Sukhorukov, Gleb B. / Magnetic Resonance Imaging for Monitoring of Magnetic Polyelectrolyte Capsule In Vivo Delivery. In: BioNanoScience. 2014 ; Vol. 4, No. 1. pp. 59-70.
@article{e9cbf6f0664c4642bb32f785828cf7f8,
title = "Magnetic Resonance Imaging for Monitoring of Magnetic Polyelectrolyte Capsule In Vivo Delivery",
abstract = "Layer-by-layer (LbL) assembled polyelectrolyte capsules have been widely studied as promising delivery systems due to their well-controlled architectures. Although their potential applications in vitro have been widely investigated, at present, it is still a challenging task to track their real-time delivery in vivo, where and how they would be located following their administration. In this work, the noninvasive magnetic resonance imaging (MRI) technique was applied to monitor the delivery of polyelectrolyte capsules in vivo, incorporating magnetite nanoparticles as imaging components. First, MRI scan was performed over 6 h after sample administration at the magnetic field of 3.0 T; magnetic capsules, both poly(allylamine hydrochloride)/poly(styrenesulfonate sodium salt)-based and poly-l-arginine hydrochloride/dextran sulfate (Parg/DS)-based, were detected mostly in the liver region, where the transverse relaxation time (T2) was shortened and hypointense images were visualized, demonstrating a contrast-enhanced MRI effect between liver and adjacent tissue. A continuous MRI scan found that the contrast-enhanced MRI effect can last up to 30 h; in the mean time, the Parg/DS-based capsules with smaller diameter were found to have a pronounced clearance effect, which resulted in a weakened MRI effect in the liver. No obvious toxicity was found in animal studies, and all mice survived after MRI scans. Histology study provided evidences to support the MRI results, and also revealed the destination of these magnetic capsules over 30 h after administration.",
keywords = "Capsule, Liver, Magnetite, MRI, Spleen",
author = "Qiangying Yi and Danyang Li and Bingbing Lin and Pavlov, {Anton M.} and Dong Luo and Qiyong Gong and Bin Song and Hua Ai and Sukhorukov, {Gleb B.}",
year = "2014",
month = "3",
day = "1",
doi = "10.1007/s12668-013-0117-2",
language = "English",
volume = "4",
pages = "59--70",
journal = "BioNanoScience",
issn = "2191-1630",
publisher = "Springer Science + Business Media",
number = "1",

}

TY - JOUR

T1 - Magnetic Resonance Imaging for Monitoring of Magnetic Polyelectrolyte Capsule In Vivo Delivery

AU - Yi, Qiangying

AU - Li, Danyang

AU - Lin, Bingbing

AU - Pavlov, Anton M.

AU - Luo, Dong

AU - Gong, Qiyong

AU - Song, Bin

AU - Ai, Hua

AU - Sukhorukov, Gleb B.

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Layer-by-layer (LbL) assembled polyelectrolyte capsules have been widely studied as promising delivery systems due to their well-controlled architectures. Although their potential applications in vitro have been widely investigated, at present, it is still a challenging task to track their real-time delivery in vivo, where and how they would be located following their administration. In this work, the noninvasive magnetic resonance imaging (MRI) technique was applied to monitor the delivery of polyelectrolyte capsules in vivo, incorporating magnetite nanoparticles as imaging components. First, MRI scan was performed over 6 h after sample administration at the magnetic field of 3.0 T; magnetic capsules, both poly(allylamine hydrochloride)/poly(styrenesulfonate sodium salt)-based and poly-l-arginine hydrochloride/dextran sulfate (Parg/DS)-based, were detected mostly in the liver region, where the transverse relaxation time (T2) was shortened and hypointense images were visualized, demonstrating a contrast-enhanced MRI effect between liver and adjacent tissue. A continuous MRI scan found that the contrast-enhanced MRI effect can last up to 30 h; in the mean time, the Parg/DS-based capsules with smaller diameter were found to have a pronounced clearance effect, which resulted in a weakened MRI effect in the liver. No obvious toxicity was found in animal studies, and all mice survived after MRI scans. Histology study provided evidences to support the MRI results, and also revealed the destination of these magnetic capsules over 30 h after administration.

AB - Layer-by-layer (LbL) assembled polyelectrolyte capsules have been widely studied as promising delivery systems due to their well-controlled architectures. Although their potential applications in vitro have been widely investigated, at present, it is still a challenging task to track their real-time delivery in vivo, where and how they would be located following their administration. In this work, the noninvasive magnetic resonance imaging (MRI) technique was applied to monitor the delivery of polyelectrolyte capsules in vivo, incorporating magnetite nanoparticles as imaging components. First, MRI scan was performed over 6 h after sample administration at the magnetic field of 3.0 T; magnetic capsules, both poly(allylamine hydrochloride)/poly(styrenesulfonate sodium salt)-based and poly-l-arginine hydrochloride/dextran sulfate (Parg/DS)-based, were detected mostly in the liver region, where the transverse relaxation time (T2) was shortened and hypointense images were visualized, demonstrating a contrast-enhanced MRI effect between liver and adjacent tissue. A continuous MRI scan found that the contrast-enhanced MRI effect can last up to 30 h; in the mean time, the Parg/DS-based capsules with smaller diameter were found to have a pronounced clearance effect, which resulted in a weakened MRI effect in the liver. No obvious toxicity was found in animal studies, and all mice survived after MRI scans. Histology study provided evidences to support the MRI results, and also revealed the destination of these magnetic capsules over 30 h after administration.

KW - Capsule

KW - Liver

KW - Magnetite

KW - MRI

KW - Spleen

UR - http://www.scopus.com/inward/record.url?scp=84926295609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926295609&partnerID=8YFLogxK

U2 - 10.1007/s12668-013-0117-2

DO - 10.1007/s12668-013-0117-2

M3 - Article

AN - SCOPUS:84926295609

VL - 4

SP - 59

EP - 70

JO - BioNanoScience

JF - BioNanoScience

SN - 2191-1630

IS - 1

ER -